Omu Anzala

Prof. Omu Anzala is a prominent virologist at the University of Nairobi, recognized for his extensive research on HIV vaccines and treatments. He has played a significant role in the advancement of HIV prevention methods, including the introduction of Lenacapavir, a long-acting injectable antiviral drug that offers a new option for individuals at risk of HIV. Anzala's work emphasizes the importance of accessible and effective HIV prevention strategies, aiming to improve health outcomes for communities affected by the virus.